Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This is a multicenter randomized trial evaluating induction treatment with
VIP-reinforced-ABVD (VIP-rABVD) versus CHOP/21 in patients with newly diagnosed peripheral T
cell lymphoma.